| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Barbara J Schwarzentraub is Director at CNMD.
Barbara J Schwarzentraub has 11 Form 4 filings on record from September 2019 to June 2026, all as Director at Conmed (CNMD), 2019–2026.
The 25 reported transactions were 15 option or other derivative awards, 8 option exercises, 1 open-market purchase and 1 open-market sale.
Counted by filing, the open-market trades come to 1 purchase worth about $100K and 1 sale worth about $252K.
The only open-market purchase was 1,442 shares of CNMD at an average $69.26 on May 8, 2024, about $100K. Twelve months later CNMD was down 17%.
The only open-market sale was 1,843 shares of CNMD at an average $136.90 on June 11, 2021, about $252K. Twelve months later CNMD was down 25%.